 Toronto Star | Should federal and provincial regulators allow plasma-for-profit clinics to ... Toronto Star ... Health Canada has approved intravenous immunoglobulins for six conditions: primary immune deficiency, chronic inflammatory demyelinating polyneuropathy, idiopathic thrombocytopenic purpura, pediatric HIV, allogenic bone marrow transplantation and ... |
